BioSpace News Archive

ERYTECH Pharma (Euronext Paris : ERYP - Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells , t oday announced that it will host a Third Quarter 20 20 conference call and webcast on Friday, November 6 , 20 20 , at 2:30 PM CET/8:30 AM EST to discuss operational highlights. The call is accessible via the below teleconfere

Prytime Medical Devices, Inc. announced that Andrew Holman has joined the company as Chief Commercialization Officer effective October 26, 2020.

A-LabInsider has recently launched their app to help biotech companies find and work with academic life science labs.

In lieu of an in-person update to the media, Dr. Theresa Tam, Canada’s Chief Public Health Officer, issued the following statement

Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that it will release results for its third quarter ended September 30, 2020 , after the market close on November 5, 2020 . Natera will host a conference call and webcast at 1:30 p.m. PT ( 4:30 p.m. ET ) to discuss its fi

BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company developing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced that the Company installed its PURE EP™ System and started conducting patient cases at Deborah Heart and Lung Center in Browns Mills, New Jersey. PURE EP™ System evaluation a

Advanced diagnostics company Prime Genomics, announced former DigitalDx EIR Robert Weigle joins as CEO, bringing over 25 years of experience building healthcare businesses.

Concerned healthcare providers in southeast Wisconsin issued a plea to the public : COVID-19 is real.

TransMedics Group, Inc. (“TransMedics”) (NASDAQ: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, announced today that members of the management team will be virtually participating in two upcoming investor conferences

Bausch Health Companies Inc. announced that on Nov. 30, 2020 it will redeem approximately $100 million aggregate principal amount of its outstanding 5.875% Senior Notes due 2023, CUSIP Nos.